-
1دورية أكاديمية
المؤلفون: Bernardino, Jose, Mocroft, Amanda, Wallet, Cedrick, de Wit, Stéphane, Katlama, Christine, Reiss, Peter, Mallon, Patrick, W, Richert, Laura, Molina, Jean-Michel, Knobel, Hernando, Morlat, Philippe, Babiker, Abdel, Pozniac, Anton, Raffi, François, Arribas, Jose, R
المساهمون: Department of Internal Medicine Madrid, Spain, Hospital Universitario La Paz Madrid, Spain -IdiPAZ - Instituto de Investigación La Paz Madrid, Spain, University College of London London (UCL), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université libre de Bruxelles (ULB), CHU Saint-Pierre, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Sorbonne Université - Faculté de Médecine (SU FM), University of Amsterdam Amsterdam = Universiteit van Amsterdam (UvA), Academic Medical Center - Academisch Medisch Centrum Amsterdam (AMC), University College Dublin Dublin (UCD), Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Génétique et Ecologie des Virus, Génétique des Virus et Pathogénèse des Maladies Virales, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), IMIM-Hospital del Mar, Generalitat de Catalunya = Generalidad de Cataluña = Government of Catalonia, Service de médecine interne et maladies infectieuses Bordeaux, CHU Bordeaux-Groupe hospitalier Saint-André, Medical Research Council Clinical Trials Unit (MRC CTU), Chelsea and Westminster Hospital, Service des maladies infectieuses et tropicales CHU Nantes, Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), NEAT is a project funded to the Instituto Superiori di Sanita-Rome, by the European Union under the Sixth Framework Programme, project number LSHP-CT-2006-037570. This analysis was also partially funded by a grant from the Ministerio de Sanidad y Asuntos Sociales de España (2009/TRA-054). The trial was also supported by Gilead Sciences, Janssen Pharmaceuticals, and Merck Laboratories, and the French National Institute for Health and Medical Research-France Recherche Nord & Sud SIDA-HIV Hépatites (Inserm-ANRS) is the sponsor and a funder of the trial.
المصدر: ISSN: 1932-6203.
مصطلحات موضوعية: [SDV]Life Sciences [q-bio]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30689664; hal-01999822; https://hal.sorbonne-universite.fr/hal-01999822Test; https://hal.sorbonne-universite.fr/hal-01999822/documentTest; https://hal.sorbonne-universite.fr/hal-01999822/file/journal.pone.0209911.pdfTest; PUBMED: 30689664
الإتاحة: https://doi.org/10.1371/journal.pone.0209911Test
https://hal.sorbonne-universite.fr/hal-01999822Test
https://hal.sorbonne-universite.fr/hal-01999822/documentTest
https://hal.sorbonne-universite.fr/hal-01999822/file/journal.pone.0209911.pdfTest -
2دورية أكاديمية
المؤلفون: Bernardino, José Ignacio, Mocroft, Amanda, Wallet, Cedrick, De Wit, Stéphane, Katlama, Christine, Reiss, Peter, Mallon, Patrick P.W., Richert, Laura, Molina, Jean-Michel, Knobel, Hernando, Morlat, Philippe, Babiker, Abdel, Pozniac, Anton, Raffi, François, Arribas, Jose
المصدر: PloS one, 14 (1
مصطلحات موضوعية: Biologie, Sciences bio-médicales et agricoles, Psychologie appliquée
وصف الملف: 1 full-text file(s): application/pdf
العلاقة: uri/info:doi/10.1371/journal.pone.0209911; uri/info:pmid/30689664; uri/info:scp/85060631958; https://dipot.ulb.ac.be/dspace/bitstream/2013/290334/3/doi_273961.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/290334Test
-
3
المؤلفون: Bernardino, Jose I., Mocroft, Amanda, Wallet, Cedrick, de Wit, Stéphane, Katlama, Christine, Reiss, Peter, Mallon, Patrick W., Richert, Laura, Molina, Jean-Michel, Knobel Freud, Hernando, Morlat, Philippe, Babiker, Abdel, Pozniac, Anton, Raffi, Francois, Arribas, José Ramón, NEAT001/ANRS143 Trial Study Group
المساهمون: UAM. Departamento de Medicina, Department of Internal Medicine [Madrid, Spain], Hospital Universitario La Paz [Madrid, Spain]-IdiPAZ - Instituto de Investigación La Paz [Madrid, Spain], University College of London [London] (UCL), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université libre de Bruxelles (ULB), CHU Saint-Pierre, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU), Sorbonne Université - Faculté de Médecine (SU FM), University of Amsterdam [Amsterdam] (UvA), Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University College Dublin [Dublin] (UCD), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Génétique et Ecologie des Virus, Génétique des Virus et Pathogénèse des Maladies Virales, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), IMIM-Hospital del Mar, Generalitat de Catalunya, Service de médecine interne et maladies infectieuses [Bordeaux], CHU Bordeaux [Bordeaux]-Groupe hospitalier Saint-André, Medical Research Council Clinical Trials Unit (MRC CTU), Chelsea and Westminster Hospital, Service des maladies infectieuses et tropicales [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), NEAT is a project funded to the Instituto Superiori di Sanita-Rome, by the European Union under the Sixth Framework Programme, project number LSHP-CT-2006-037570. This analysis was also partially funded by a grant from the Ministerio de Sanidad y Asuntos Sociales de España (2009/TRA-054). The trial was also supported by Gilead Sciences, Janssen Pharmaceuticals, and Merck Laboratories, and the French National Institute for Health and Medical Research-France Recherche Nord & Sud SIDA-HIV Hépatites (Inserm-ANRS) is the sponsor and a funder of the trial., Gestionnaire, Hal Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Global Health, APH - Aging & Later Life
المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE
PLoS ONE, Public Library of Science, 2019, 14 (1), pp.e0209911. ⟨10.1371/journal.pone.0209911⟩
PLoS ONE, 14(1):e0209911. Public Library of Science
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
PLoS ONE, Vol 14, Iss 1, p e0209911 (2019)
PloS one, 14 (1مصطلحات موضوعية: Leptin, 0301 basic medicine, Male, Time Factors, Lipodystrophy, Physiology, Peptide Hormones, [SDV]Life Sciences [q-bio], Psychologie appliquée, Pathology and Laboratory Medicine, Biochemistry, Body Mass Index, Fats, 0302 clinical medicine, Bone Density, Immune Physiology, Medicine and Health Sciences, 030212 general & internal medicine, Musculoskeletal System, Immune Response, Innate Immune System, therapy HAART, Multidisciplinary, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination, Sida -- Tractament, Sciences bio-médicales et agricoles, Lipids, 3. Good health, [SDV] Life Sciences [q-bio], Arms, Adipose Tissue, Connective Tissue, Body Composition, Cytokines, Medicine, Female, Anatomy, Biologie, Research Article, medicine.drug, Adult, medicine.medical_specialty, Medicina, Science, Immunology, Urology, Adipokine, Emtricitabine, 03 medical and health sciences, Signs and Symptoms, Adipokines, Diagnostic Medicine, Raltegravir Potassium, medicine, Humans, Bone, Darunavir, Cos humà -- Composició, Inflammation, business.industry, Biology and Life Sciences, HIV, Molecular Development, Raltegravir, 030112 virology, Hormones, Fibroblast Growth Factor-23, Biological Tissue, Body Limbs, Immune System, Lean body mass, Ritonavir, business, Body mass index, Developmental Biology
وصف الملف: application/pdf; 1 full-text file(s): application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab533c8d83d1f3661b03ec57a14dd15cTest
https://hdl.handle.net/10486/687407Test -
4دورية أكاديمية
المؤلفون: Bernardino, Jose I., Mocroft, Amanda, Wallet, Cedrick, de Wit, Stéphane, Katlama, Christine, Reiss, Peter, Mallon, Patrick W., Richert, Laura, Molina, Jean-Michel, Knobel Freud, Hernando, Morlat, Philippe, Babiker, Abdel, Pozniac, Anton, Raffi, Francois, Arribas, José Ramón, NEAT001/ANRS143 Trial Study Group
مصطلحات موضوعية: Sida -- Tractament, Cos humà -- Composició
وصف الملف: application/pdf
العلاقة: info:eu-repo/grantAgreement/EC/FP6/037570; Bernardino JI, Mocroft A, Wallet C, de Wit S, Katlama C, Reiss P. et al. Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial. PLoS One. 2019 Jan 28;14(1):e0209911. DOI:10.1371/journal.pone.0209911; http://hdl.handle.net/10230/41981Test; http://dx.doi.org/10.1371/journal.pone.0209911Test